Capsule Stock

capsulecares.comHealthcare / Healthcare providers & servicesFounded: 2016Funding to Date: $180.56MM

Capsule is a new kind of pharmacy that has invested in technology, experience, and care. Instead of mailing prescriptions in 10-14 days, Capsule hand deliver them on the same day patients see your doctor. They've engineered a holistic pharmacy experience that provides personalized and effortless care, setting a new standard for how people interact with their medications. This company was founded by Eric Kinariwala in 2016 and is headquartered in New York, NY.

Register To Buy and Sell Shares

For more details on financing and valuation for Capsule, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Capsule’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Capsule.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Sonia Patel
Co-Founder & Chief Pharmacist
Eric Kinariwala
Co-Founder & Chief Executive Officer
Anne Hatcher
Chief People Officer
Matthew Keeler
Chief Growth Officer
Sarah Fraser
Chief Financial Officer

Board Members

Adam Silverschotz
TCV
John-Paul Van Arsdale
Glade Brook Capital Partners

Frequently Asked Questions About Capsule’s Stock

plusminus
Can you buy Capsule’s stock?
Capsule is not publicly traded on NYSE or NASDAQ in the U.S. To buy Capsule’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell Capsule’s stock?
Yes, you can sell stock of a private company like Capsule. Forge can help you sell your Capsule stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is Capsule’s stock price?
Capsule is a privately held company and therefore does not have a public stock price. However, you may access Capsule’s private market stock price with Forge Data.
plusminus
What is Capsule’s stock ticker symbol?
Capsule does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Beacon Fund leads $1.5M round in decentralized social media app Capsule » CryptoNinjas
Beacon Fund, a dedicated crypto fund by Polychain Capital focused on growing the DFINITY Internet Computer, announced it has led a $1.5 million round in
Capsule CEO on how company differs from Amazon's digital pharmacy
Capsule Pharmacy CEO Eric Kinariwala joins CNBC'S "Squawk Alley" team to discuss the e-commerce aspects of the pharmacy industry and what it means for Amazon to enter the market.
Nasa poised to return to crewed spaceflight with SpaceX capsule launch
Public-private partnership with Elon Musk’s company to send four astronauts to international space station on Saturday
Updated on: Apr 15, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.